V7B Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Assembly Biosciences Inc

Watchlist Manager

Watchlist

Price: 21.9 EUR -4.78% Market Closed

Market Cap: €346.5m

	Assembly Biosciences Inc F:V7B	US
	Amdocs Ltd NASDAQ:DOX	US
	Teleperformance SE F:RCF	FR
M	Mulberry Group PLC F:MUY	UK
T	Target Corp XHAM:DYH	US
T	TRYP Therapeutics Inc CNSX:TRYP	CA
	GAM Holding AG SIX:GAM	CH
Z	Zoom Video Communications Inc F:5ZM	US
	Barito Pacific Tbk PT F:OB8	ID
	Coforge Ltd NSE:COFORGE	IN
	Yokohama Rubber Co Ltd TSE:5101	JP

Profitability Summary

Assembly Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-17%

Negative 3Y Average Operating Margin

-255%

Negative Net Margin

-8%

Negative 3Y Average Net Margin

-234%

Negative Free Cash Flow Margin

-57%

Negative 3Y Average Free Cash Flow Margin

-1%

Negative ROE

-5%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-772%

ROIC is Increasing

-553% > -164%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.